Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole

Open access

Published version of a preprint

Abstract

Candida glabrata is an opportunistic pathogen whose incidence has been increasing in the last 40 years. It has risen to become the most prominent non- Candida albicans Candida (NCAC) species to cause candidemia, constituting about one-third of isolates in the United States, and steadily increasing in European countries and in Australia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01128-21

Cites

Statistics

Figures

FIG 1 Both Cgmip1Δ and Scmip1Δ show typical petite phenotypes. (A) Small colonies and loss of mitochondrial reductive power, as indicated by lack of tetrazolium dye reduction; (B) lack of growth in alternative carbon sources such as glycerol and absence of mitochondrial DNA (mtDNA) as determined by optical density and qPCR (n = 3 for each type of experiment, color by mean); (C) high resistance to azoles, including fluconazole (FL), voriconazole (VC), and clotrimazole (CL), and (D) overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). C.g., C. glabrata; S.c., S. cerevisiae.
FIG 1 Both Cgmip1Δ and Scmip1Δ show typical petite phenotypes. (A) Small colonies and loss of mitochondrial reductive power, as indicated by lack of tetrazolium dye reduction; (B) lack of growth in alternative carbon sources such as glycerol and absence of mitochondrial DNA (mtDNA) as determined by optical density and qPCR (n = 3 for each type of experiment, color by mean); (C) high resistance to azoles, including fluconazole (FL), voriconazole (VC), and clotrimazole (CL), and (D) overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). C.g., C. glabrata; S.c., S. cerevisiae.CC BY · PubMed Central
FIG 2 C. glabrata and S. cerevisiae petite phenotypes differ in their survival after phagocytosis. (A) Cgmip1Δ survives phagocytosis by hMDMs much better than its parental wild type at early time points up to 6 h—in contrast to Scmip1Δ, which does not show any change in survival compared to its wild type (mean ± SD, n = 9 with 3 different donors in 3 independent experiments; each point represents the mean of 3 technical replicates). (B) Cgmip1Δ is taken up at a higher rate than the wild type by macrophages (mean ± SD, n = 9 with 3 different donors in 3 independent experiments; each point represents the mean of 3 technical replicates), and its accessible cell wall structures differ from the wild type (mean ± SD, n = 3 independent experiments with 3 technical replicates each). (C) In contrast to the wild type, Cgmip1Δ does not replicate within the phagosome as shown by FACS (left) and by the lack of FITC-unstained daughter cells (right). These are present in the wild type (blue arrows), in contrast to the mutant, which shows only mother cells (yellow arrows) (representative picture shown). Quantitative data are the mean ± SD; n = 12 with 3 different donors in 4 independent experiments; each point represents the mean of 3 technical replicates. Statistically significantly different values (unpaired, two-tailed Student’s t test on log-transformed ratios) are indicated by asterisks as follows: ***, P ≤ 0.001. C.g., C. glabrata; S.c., S. cerevisiae.
FIG 2 C. glabrata and S. cerevisiae petite phenotypes differ in their survival after phagocytosis. (A) Cgmip1Δ survives phagocytosis by hMDMs much better than its parental wild type at early time points up to 6 h—in contrast to Scmip1Δ, which does not show any change in survival compared to its wild type (mean ± SD, n = 9 with 3 different donors in 3 independent experiments; each point represents the mean of 3 technical replicates). (B) Cgmip1Δ is taken up at a higher rate than the wild type by macrophages (mean ± SD, n = 9 with 3 different donors in 3 independent experiments; each point represents the mean of 3 technical replicates), and its accessible cell wall structures differ from the wild type (mean ± SD, n = 3 independent experiments with 3 technical replicates each). (C) In contrast to the wild type, Cgmip1Δ does not replicate within the phagosome as shown by FACS (left) and by the lack of FITC-unstained daughter cells (right). These are present in the wild type (blue arrows), in contrast to the mutant, which shows only mother cells (yellow arrows) (representative picture shown). Quantitative data are the mean ± SD; n = 12 with 3 different donors in 4 independent experiments; each point represents the mean of 3 technical replicates. Statistically significantly different values (unpaired, two-tailed Student’s t test on log-transformed ratios) are indicated by asterisks as follows: ***, P ≤ 0.001. C.g., C. glabrata; S.c., S. cerevisiae.CC BY · PubMed Central
FIG 3 The petite phenotype emerges from the wild type after phagocytosis. (A) Cgmip1Δ shows a higher rate of survival up to 1 day of coincubation but loses this advantage over extended periods of intracellular existence (n = 5 with 1 different donor in each of the 5 independent experiments; each point represents a single survival test). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; ***, P ≤ 0.001. (B) Cells with the petite phenotypes arise from the wild type during coincubation with hMDMs (red) at a much higher rate than the spontaneous appearance of petite in RPMI (blue). The time points with the highest frequency of petite emergence correspond to the time point of increased fitness of Cgmip1Δ during phagocytosis (Red: n = 5 with 1 different donor in each of the 5 independent experiments and 4 technical replicates each. Blue: n = 3 in 3 different experiments with 6 technical replicates. Mean ± SD of the frequencies of petite emergence at each time point). (C) Phenotype characterization reveals the hMDMs-derived strains (MO-1 to -3) to be indeed petite. From the top left, small colony forming and lack of mitochondrial reductive power, lack of growth in alternative carbon sources, absence of mitochondrial DNA (mtDNA), high resistance to azoles (all n = 3 with mean values or representative picture shown) and overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). FL, fluconazole; VC, voriconazole; CL, clotrimazole; S.c., S. cerevisiae.
FIG 3 The petite phenotype emerges from the wild type after phagocytosis. (A) Cgmip1Δ shows a higher rate of survival up to 1 day of coincubation but loses this advantage over extended periods of intracellular existence (n = 5 with 1 different donor in each of the 5 independent experiments; each point represents a single survival test). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; ***, P ≤ 0.001. (B) Cells with the petite phenotypes arise from the wild type during coincubation with hMDMs (red) at a much higher rate than the spontaneous appearance of petite in RPMI (blue). The time points with the highest frequency of petite emergence correspond to the time point of increased fitness of Cgmip1Δ during phagocytosis (Red: n = 5 with 1 different donor in each of the 5 independent experiments and 4 technical replicates each. Blue: n = 3 in 3 different experiments with 6 technical replicates. Mean ± SD of the frequencies of petite emergence at each time point). (C) Phenotype characterization reveals the hMDMs-derived strains (MO-1 to -3) to be indeed petite. From the top left, small colony forming and lack of mitochondrial reductive power, lack of growth in alternative carbon sources, absence of mitochondrial DNA (mtDNA), high resistance to azoles (all n = 3 with mean values or representative picture shown) and overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). FL, fluconazole; VC, voriconazole; CL, clotrimazole; S.c., S. cerevisiae.CC BY · PubMed Central
FIG 4 The petite phenotype triggered by fluconazole increases survival of phagocytosis at early time points. (A) Fluconazole-induced petites show the petite phenotype similar to Cgmip1Δ—small colonies and lack of mitochondrial reductive power, lack of growth in alternative carbon sources, absence of mitochondrial DNA (mtDNA), high resistance to azoles (all n = 3 with mean values or representative picture shown), and overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). FL, fluconazole; VC, voriconazole; CL, clotrimazole. (B) Fluconazole-induced petites (FL-1 to FL-3) show better survival of phagocytosis at early time points (mean ± SD, n = 3 with 1 donor in 3 independent experiments; each point represents a mean of 3 different colonies per donor, and each colony has 3 technical replicates). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; **, P ≤ 0.01. C.g., C. glabrata.
FIG 4 The petite phenotype triggered by fluconazole increases survival of phagocytosis at early time points. (A) Fluconazole-induced petites show the petite phenotype similar to Cgmip1Δ—small colonies and lack of mitochondrial reductive power, lack of growth in alternative carbon sources, absence of mitochondrial DNA (mtDNA), high resistance to azoles (all n = 3 with mean values or representative picture shown), and overexpression of efflux pump-related genes (mean ± SD, n = 3 independent experiments with 3 technical replicates each). FL, fluconazole; VC, voriconazole; CL, clotrimazole. (B) Fluconazole-induced petites (FL-1 to FL-3) show better survival of phagocytosis at early time points (mean ± SD, n = 3 with 1 donor in 3 independent experiments; each point represents a mean of 3 different colonies per donor, and each colony has 3 technical replicates). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; **, P ≤ 0.01. C.g., C. glabrata.CC BY · PubMed Central
FIG 5 Cgmip1Δ shows higher basal expression of stress response-related genes and grows better under ER stress. (A) Petite variants of C. glabrata show high constitutive expression of stress-response genes even under nonstressed conditions (YPD) (mean ± SD, n = 3 independent experiments with 3 technical replicates each), and (B) exhibit better growth than their wild type under different ER stresses on plates as well as with tunicamycin (TM) in liquid cultures (mean ± SD, n = 3 independent experiments or representative picture shown); FL-1 to FL-3, fluconazole-induced petites; MO-1 to MO-3 macrophage-derived petites; C.g., C. glabrata.
FIG 5 Cgmip1Δ shows higher basal expression of stress response-related genes and grows better under ER stress. (A) Petite variants of C. glabrata show high constitutive expression of stress-response genes even under nonstressed conditions (YPD) (mean ± SD, n = 3 independent experiments with 3 technical replicates each), and (B) exhibit better growth than their wild type under different ER stresses on plates as well as with tunicamycin (TM) in liquid cultures (mean ± SD, n = 3 independent experiments or representative picture shown); FL-1 to FL-3, fluconazole-induced petites; MO-1 to MO-3 macrophage-derived petites; C.g., C. glabrata.CC BY · PubMed Central
FIG 6 The Cgmip1Δ petite phenotype seems to be adaptive under infection-like conditions but not in commensal-like conditions. (A) The ratio of recovered CgMIP1-deleted to wild-type C. glabrata cells was low when they were incubated separately on vaginal cells (Cgmip1Δ/–). The presence of Lactobacillus rhamnosus (L. r.) further shifts that ratio toward a lower recovery of Cgmip1Δ, and these effects are exacerbated in a direct competition in the same wells (C. glabrata [C. g.] WT + CgmipΔ). Data shown are the mean ± SD; n = 3 independent experiments. (B) In an infection model in the presence of fluconazole (FL), the effect is inverted. Without fluconazole, CgmipΔ is outcompeted as before (note the scale), but it has a decisive advantage in the presence of the antifungal drug, independent of the commensal bacteria (mean ± SD, n = 3 independent experiments). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; ***, P ≤ 0.001.
FIG 6 The Cgmip1Δ petite phenotype seems to be adaptive under infection-like conditions but not in commensal-like conditions. (A) The ratio of recovered CgMIP1-deleted to wild-type C. glabrata cells was low when they were incubated separately on vaginal cells (Cgmip1Δ/–). The presence of Lactobacillus rhamnosus (L. r.) further shifts that ratio toward a lower recovery of Cgmip1Δ, and these effects are exacerbated in a direct competition in the same wells (C. glabrata [C. g.] WT + CgmipΔ). Data shown are the mean ± SD; n = 3 independent experiments. (B) In an infection model in the presence of fluconazole (FL), the effect is inverted. Without fluconazole, CgmipΔ is outcompeted as before (note the scale), but it has a decisive advantage in the presence of the antifungal drug, independent of the commensal bacteria (mean ± SD, n = 3 independent experiments). Statistically significantly different values (unpaired, two-sided Student’s t test on log-transformed ratios) are indicated by asterisks as follows: *, P ≤ 0.05; ***, P ≤ 0.001.CC BY · PubMed Central
FIG 7 Mutation on the protein sequence of CgMIP1 of C. glabrata clinical strains compared to the wild type. Wild type (ATCC 2001, WT); the first 14 strains marked in bold are petite mutants, and below there are the 17 respiratory-competent strains. Gray, predicted mitochondrial signal peptide of the wild type; blue, amino acid substitutions; green, insertions; red, deletions. The black lines on top indicate the amino acid position every 50 amino acids. The black lines next to the strain names indicate that those strains have been isolated from the same patient.
FIG 7 Mutation on the protein sequence of CgMIP1 of C. glabrata clinical strains compared to the wild type. Wild type (ATCC 2001, WT); the first 14 strains marked in bold are petite mutants, and below there are the 17 respiratory-competent strains. Gray, predicted mitochondrial signal peptide of the wild type; blue, amino acid substitutions; green, insertions; red, deletions. The black lines on top indicate the amino acid position every 50 amino acids. The black lines next to the strain names indicate that those strains have been isolated from the same patient.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 82 · Cited by 36

Metadata

Authors
Siscar-Lewin, S., Gabaldón, T., Aldejohann, A. M., Kurzai, O., Hube, B., & Brunke, S.
Affiliations
  • Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) (DE)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • University of Würzburg (DE)
Corresponding author
Brunke, Sascha
Venue
mBio
Published
2021-06-29
Volume
12
Issue
3
Pages
e0112821-e0112821
ISSN
2150-7511 (ISSN-L)
OpenAlex
W3165130988
Cited by
36
References
82
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 1
FWCI
1.74
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UPCommons institutional repository (Universitat Politècnica de Catalunya) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • FSU | Jena School for Microbial Communication, Friedrich-Schiller-Universität Jena
  • Friedrich-Schiller-Universität Jena (ID 390713860)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
Candida glabrata, fluconazole resistance, phagocytic killing, candidemia, non-albicans Candida, antifungal resistance
MeSH terms
Antifungal Agents, Candidiasis, Humans, Macrophages, Microbial Sensitivity Tests, Mitochondria, Phagocytes, Phagocytosis, Virulence, Fluconazole, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Candida glabrata

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole. https://app.cochat.ai/papers/10.1128/mbio.01128-21
The paper
Siscar-Lewin, S., Gabaldón, T., Aldejohann, A. M., Kurzai, O., Hube, B., & Brunke, S. (2021). Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole. mBio. https://doi.org/10.1128/mbio.01128-21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.